Holen Sie sich die Stockscreener-App
5.22
0.95%
-0.05
Handel nachbörslich:
5.16
-0.06
-1.15%
Schlusskurs vom Vortag:
$5.27
Offen:
$5.27
24-Stunden-Volumen:
100.76K
Relative Volume:
0.65
Marktkapitalisierung:
$260.81M
Einnahmen:
$15.33M
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-2.9791
EPS:
-1.7522
Netto-Cashflow:
-
1W Leistung:
-0.76%
1M Leistung:
-24.02%
6M Leistung:
+14.47%
1J Leistung:
-1.51%
1-Tages-Spanne:
$5.16
$5.32
1-Wochen-Bereich:
$5.16
$5.8721
52-Wochen-Spanne:
$3.42
$7.95
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Firmenname
Trisalus Life Sciences Inc
Sektor
Branche
Telefon
415 336 8917
Adresse
6272 WEST 91ST AVENUE, WESTMINSTER
Vergleichen Sie TLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.22 | 263.31M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Eingeleitet | ROTH MKM | Buy |
| 2024-10-25 | Eingeleitet | Northland Capital | Outperform |
| 2024-09-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-30 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
Macro Review: What is TriSalus Life Sciences Inc Equity Warrants P E ratio telling usWeekly Volume Report & Comprehensive Market Scan Insights - baoquankhu1.vn
Aug Spikes: Does TriSalus Life Sciences Inc have pricing power2025 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
Aug PreEarnings: Will TriSalus Life Sciences Inc benefit from rate cutsJuly 2025 Movers & Reliable Intraday Trade Alerts - baoquankhu1.vn
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Trisalus life sciences CEO buys $50,302 in stock - MSN
Is TriSalus Life Sciences Inc. Equity Warrant forming a bullish divergenceDividend Hike & Low Risk High Reward Trade Ideas - bollywoodhelpline.com
What catalysts could drive TriSalus Life Sciences Inc. Equity Warrant stock higherWeekly Trading Summary & Advanced Technical Signal Analysis - bollywoodhelpline.com
Published on: 2026-01-18 10:38:25 - baoquankhu1.vn
TriSalus Life Sciences (NASDAQ:TLSI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Rate Hike: Is TriSalus Life Sciences Inc stock a value trapRecession Risk & AI Driven Stock Price Forecasts - baoquankhu1.vn
TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Does TriSalus Life Sciences Inc. have strong EBITDA marginsStock Correlation Metrics & AI-Based Insights for Consistent Profits - bollywoodhelpline.com
TriSalus Life Sciences reports 60% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Gap Down: Does TriSalus Life Sciences Inc have strong EBITDA marginsShort Setup & Consistent Profit Trading Strategies - baoquankhu1.vn
Oncology company TriSalus boosts sales in fourth quarter - bizwest.com
Jobs Data: Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrendJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
TriSalus Life Sciences reports 60% revenue growth in Q4 2025 - Investing.com
Cancer-focused medical tech firm’s sales jump 60% in latest quarter - Stock Titan
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - bdtonline.com
Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrendDip Buying & High Conviction Trade Alerts - baoquankhu1.vn
What risks investors should watch in TriSalus Life Sciences Inc. Equity Warrant stockWeekly Trade Summary & Short-Term High Return Strategies - ulpravda.ru
TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Up 13.9% – Should You Buy? - Defense World
Can Sumeet Industries Limited (514211) Maintain Its ValuationEquity Performance Review & Use Our Sector Rotation Strategy for Gains - bollywoodhelpline.com
Trisalus Life Sciences CFO buys $33,900 in common stock - MSN
Is TriSalus Life Sciences Inc. stock vulnerable to regulatory risksJuly 2025 Big Picture & Community Verified Trade Signals - Улправда
How geopolitical risks impact CDP stockPortfolio Update Report & Consistent Profit Focused Trading Strategies - ulpravda.ru
Will National Research Corporation stock deliver shareholder valueGap Down & Expert Approved Momentum Ideas - ulpravda.ru
Is NeuroSense Therapeutics Ltd. stock resilient to inflationGlobal Markets & Weekly High Momentum Picks - ulpravda.ru
Will TriSalus Life Sciences Inc. Equity Warrant stock deliver long term returns2025 Short Interest & Consistent Profit Trading Strategies - Улправда
Is TriSalus Life Sciences Inc. Equity Warrant stock safe for conservative investorsJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - Улправда
Will TriSalus Life Sciences Inc. stock keep outperforming rivalsJuly 2025 Setups & Community Verified Swing Trade Signals - Улправда
Will TriSalus Life Sciences Inc. Equity Warrant stock maintain momentum in 2025 - Улправда
Aug Sentiment: Will TriSalus Life Sciences Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Gainers & Weekly Consistent Profit Watchlists - Улправда
Will Bulten AB (publ) (3FB) stock return to pre crash levels2025 Dividend Review & Technical Entry and Exit Tips - ulpravda.ru
2026 world cup mexico quarterfinals playmakers pressing system expert tips breakdownMid Cap Growth Trends & Low Cost Portfolio Growth - ulpravda.ru
Analysts Spot Bullish Divergence in Oberoi Realty LimitedSector Performance Review & Double Digit Portfolio Growth - bollywoodhelpline.com
Why TriSalus Life Sciences Inc. stock remains resilient2026 world cup usa national team qualification goalkeepers possession football odds analysis expert opinion - Улправда
Expanding Indications and Diversified Revenue Base Support Buy Rating on TriSalus Life Sciences - TipRanks
TriSalus Life Sciences launches preferred stock exchange - MSN
Bullish Divergence Spotted in Vibrant Global Capital Limited MomentumRisk-Reward Ratio Analysis & Market Monitoring and Alerts - bollywoodhelpline.com
Finance Limited Stock Approaches Key Moving AverageCapital Gains Strategies & Superior Wealth Growth - bollywoodhelpline.com
Sathavahana Ispat Limited (526093) Announces Strategic ShiftLong-Term Investment Plans & Free Get Breakthrough Ideas - bollywoodhelpline.com
Epigral Limited Builds Base for Possible ReboundFundamental Stock Analysis & Low Cost Trading Tips - bollywoodhelpline.com
Will Sun Communities Inc. stock attract ESG investorsPortfolio Diversification Tips & Affordable Market Trading - bollywoodhelpline.com
Use hedged strategies (never naked short)Dividend Reinvestment Plans & Free Superior Stock Performance - bollywoodhelpline.com
Analysts’ Top Healthcare Picks: Assertio Therapeutics (ASRT), REPRO-MED Systems (KRMD) - The Globe and Mail
Portfolio rebalancing decisions can be guided by facts not emotionsStock Price Divergence & AI Alerts You Can Actually Trust - bollywoodhelpline.com
Is Harshdeep Hortico Limited (544105) a Good Long Term BetDividend Stability Analysis & Small Capital Gains - bollywoodhelpline.com
Energy Limited Matches Institutional Buying FilterInterest Rate Changes & Identify Breakout Stocks - bollywoodhelpline.com
Terumo (OTCMKTS:TRUMY) vs. TriSalus Life Sciences (NASDAQ:TLSI) Critical Survey - Defense World
Contrasting Stagezero Life Sciences (OTCMKTS:SZLSF) and TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):